Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSTI
DateTimeSourceHeadlineSymbolCompany
09/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
01/06/202321:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
09/05/202321:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
25/04/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202312:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202312:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202313:59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202313:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202311:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
13/02/202321:39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
06/02/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
24/01/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
28/12/202221:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
22/12/202213:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
19/12/202221:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
10/11/202221:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
13/10/202221:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
29/09/202215:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202222:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202221:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202214:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202212:00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
25/07/202206:00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
17/07/202213:20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
13/07/202214:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
13/07/202211:00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
23/06/202221:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
15/05/202213:25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
28/03/202208:00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
23/03/202211:30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI